BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 35918373)

  • 1. Discriminators of pseudoprogression and true progression in high-grade gliomas: A systematic review and meta-analysis.
    Taylor C; Ekert JO; Sefcikova V; Fersht N; Samandouras G
    Sci Rep; 2022 Aug; 12(1):13258. PubMed ID: 35918373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Magnetic resonance perfusion for differentiating low-grade from high-grade gliomas at first presentation.
    Abrigo JM; Fountain DM; Provenzale JM; Law EK; Kwong JS; Hart MG; Tam WWS
    Cochrane Database Syst Rev; 2018 Jan; 1(1):CD011551. PubMed ID: 29357120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amide proton transfer-weighted MRI in distinguishing high- and low-grade gliomas: a systematic review and meta-analysis.
    Suh CH; Park JE; Jung SC; Choi CG; Kim SJ; Kim HS
    Neuroradiology; 2019 May; 61(5):525-534. PubMed ID: 30666352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic accuracy of glioma pseudoprogression identification with positron emission tomography imaging: a systematic review and meta-analysis.
    Ouyang ZQ; Zheng GR; Duan XR; Zhang XR; Ke TF; Bao SS; Yang J; He B; Liao CD
    Quant Imaging Med Surg; 2023 Aug; 13(8):4943-4959. PubMed ID: 37581048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Machine learning imaging applications in the differentiation of true tumour progression from treatment-related effects in brain tumours: A systematic review and meta-analysis.
    Bhandari A; Marwah R; Smith J; Nguyen D; Bhatti A; Lim CP; Lasocki A
    J Med Imaging Radiat Oncol; 2022 Sep; 66(6):781-797. PubMed ID: 35599360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perfusion magnetic resonance imaging in the differentiation between glioma recurrence and pseudoprogression: a systematic review, meta-analysis and meta-regression.
    Zhang J; Wang Y; Wang Y; Xiao H; Chen X; Lei Y; Feng Z; Ma X; Ma L
    Quant Imaging Med Surg; 2022 Oct; 12(10):4805-4822. PubMed ID: 36185045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of Tumour Progression and Pseudoprogression in High-Grade Gliomas: a Systematic Review and Meta-Analysis.
    Abbasi AW; Westerlaan HE; Holtman GA; Aden KM; van Laar PJ; van der Hoorn A
    Clin Neuroradiol; 2018 Sep; 28(3):401-411. PubMed ID: 28466127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic Values of DCE-MRI and DSC-MRI for Differentiation Between High-grade and Low-grade Gliomas: A Comprehensive Meta-analysis.
    Liang J; Liu D; Gao P; Zhang D; Chen H; Shi C; Luo L
    Acad Radiol; 2018 Mar; 25(3):338-348. PubMed ID: 29223713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic accuracy of dynamic contrast-enhanced perfusion MRI in stratifying gliomas: A systematic review and meta-analysis.
    Okuchi S; Rojas-Garcia A; Ulyte A; Lopez I; Ušinskienė J; Lewis M; Hassanein SM; Sanverdi E; Golay X; Thust S; Panovska-Griffiths J; Bisdas S
    Cancer Med; 2019 Sep; 8(12):5564-5573. PubMed ID: 31389669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Applying amide proton transfer-weighted MRI to distinguish pseudoprogression from true progression in malignant gliomas.
    Ma B; Blakeley JO; Hong X; Zhang H; Jiang S; Blair L; Zhang Y; Heo HY; Zhang M; van Zijl PC; Zhou J
    J Magn Reson Imaging; 2016 Aug; 44(2):456-62. PubMed ID: 26788865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic accuracy of magnetic resonance imaging techniques for treatment response evaluation in patients with high-grade glioma, a systematic review and meta-analysis.
    van Dijken BRJ; van Laar PJ; Holtman GA; van der Hoorn A
    Eur Radiol; 2017 Oct; 27(10):4129-4144. PubMed ID: 28332014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unsupervised consensus cluster analysis of [18F]-fluoroethyl-L-tyrosine positron emission tomography identified textural features for the diagnosis of pseudoprogression in high-grade glioma.
    Kebir S; Khurshid Z; Gaertner FC; Essler M; Hattingen E; Fimmers R; Scheffler B; Herrlinger U; Bundschuh RA; Glas M
    Oncotarget; 2017 Jan; 8(5):8294-8304. PubMed ID: 28030820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fully automated analysis combining [
    Paprottka KJ; Kleiner S; Preibisch C; Kofler F; Schmidt-Graf F; Delbridge C; Bernhardt D; Combs SE; Gempt J; Meyer B; Zimmer C; Menze BH; Yakushev I; Kirschke JS; Wiestler B
    Eur J Nucl Med Mol Imaging; 2021 Dec; 48(13):4445-4455. PubMed ID: 34173008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longitudinal DSC-MRI for Distinguishing Tumor Recurrence From Pseudoprogression in Patients With a High-grade Glioma.
    Boxerman JL; Ellingson BM; Jeyapalan S; Elinzano H; Harris RJ; Rogg JM; Pope WB; Safran H
    Am J Clin Oncol; 2017 Jun; 40(3):228-234. PubMed ID: 25436828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 18F-FET-PET imaging in high-grade gliomas and brain metastases: a systematic review and meta-analysis.
    Singnurkar A; Poon R; Detsky J
    J Neurooncol; 2023 Jan; 161(1):1-12. PubMed ID: 36502457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imaging glioma biology: spatial comparison of amino acid PET, amide proton transfer, and perfusion-weighted MRI in newly diagnosed gliomas.
    Schön S; Cabello J; Liesche-Starnecker F; Molina-Romero M; Eichinger P; Metz M; Karimov I; Preibisch C; Keupp J; Hock A; Meyer B; Weber W; Zimmer C; Pyka T; Yakushev I; Gempt J; Wiestler B
    Eur J Nucl Med Mol Imaging; 2020 Jun; 47(6):1468-1475. PubMed ID: 31953672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amide proton transfer-weighted magnetic resonance image-guided stereotactic biopsy in patients with newly diagnosed gliomas.
    Jiang S; Eberhart CG; Zhang Y; Heo HY; Wen Z; Blair L; Qin H; Lim M; Quinones-Hinojosa A; Weingart JD; Barker PB; Pomper MG; Laterra J; van Zijl PCM; Blakeley JO; Zhou J
    Eur J Cancer; 2017 Sep; 83():9-18. PubMed ID: 28704644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perfusion MRI as a diagnostic biomarker for differentiating glioma from brain metastasis: a systematic review and meta-analysis.
    Suh CH; Kim HS; Jung SC; Choi CG; Kim SJ
    Eur Radiol; 2018 Sep; 28(9):3819-3831. PubMed ID: 29619517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accuracy of ADC derived from DWI for differentiating high-grade from low-grade gliomas: Systematic review and meta-analysis.
    Wang QP; Lei DQ; Yuan Y; Xiong NX
    Medicine (Baltimore); 2020 Feb; 99(8):e19254. PubMed ID: 32080132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.